| Tag | Content |
|---|
EnhancerAtlas ID | HS073-03837 |
Organism | Homo sapiens |
Tissue/cell | GM19238 |
Coordinate | chr13:111329450-111330360 |
Target genes | |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| SREBF1 | MA0595.1 | chr13:111329721-111329731 | ATCACCCCAC | + | 6.02 | | SREBF1 | MA0595.1 | chr13:111329793-111329803 | ATCACCCCAC | + | 6.02 | | SREBF1 | MA0595.1 | chr13:111329940-111329950 | ATCACCCCAC | + | 6.02 | | SREBF1 | MA0595.1 | chr13:111330113-111330123 | ATCACCCCAC | + | 6.02 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_09490 | chr13:111327877-111331277 | CD14 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH13I110675 | chr13 | 111327985 | 111329942 |
|
Enhancer Sequence | CTGCAGATGA CAAACGGTAC ATCAGTGGGA AGAAGCTCAG TCACCCCACC ACGGATGCTC 60
AGACATTCAC CCCCACCACA GAAACCCAGA CAGTCACCCC CACCATGGAA ACACAGAAAA 120
TCACCCCAAC ATGGAAACCC AGACAGTCAC CCCCACCACA GAGACCCAGT CACCCCCACC 180
ACGGAAACAC AGAAAATCAC CCCAACATGG AAACTCAGAC AGTCACCCCC ACCACGGGGA 240
CCCAGTCACC CCCACCACGG AAACACAGAA AATCACCCCA CCATGGAAAC CCAGACAGTC 300
ACCCTTACCA CGGAAACCCA ATCACCCCCA CCATGGAAAC ACAATCACCC CACCACGGAC 360
ACGCAGACAG TCACCCCACC ACAGAAACTC AGTCACCCCC ACCAGGGAGA CCCAGACAAT 420
CACACCACAG AAACTCAGAC AGCCACCCCG CCACGGAAAC CCAGACAGTC ACCCCCACCA 480
TGGAAACACA ATCACCCCAC CACGGACACG CAGACAGTCA CCCCACCACA GAAACTCAGT 540
CACCCCCACC AGGGAGACCC AGACAATCAC ACCACAGAAA CTCAGACAGC CACCCCGCCA 600
CGGAAACCCA GACAGCCACC CCGCCACGGA AACCCAGACA GTCACCCCCA CCATGGAAAC 660
ACAATCACCC CACCACGGAC ACGCAGACAG TCACCCCTAC CATGAAAGCC CAGACTGTCA 720
CCCCACCAGG GAAGCCCAGG CTGTCACCAC CACCTCACCC CCACCACAGA AGCCCAGATA 780
GTCACCCCCC ACCACAGAAA CTCAGCTGGT CACCCCCACC AGGGAAATCC AGCCGGCCAC 840
CCCGGTGGAA GCCCCTCCAG CCGCCAGTGG GCAGCACGCC CCAGGCTGTG TCTCTTCGAA 900
GGAGCCTTGG 910
|
